Table 2. Antimicrobial treatmentsa the dogs had received before the NDM-Escherichia coli finding, Finland, 2013–2015.
| Dog A | Dog B | ||
|---|---|---|---|
| Topical | Systemic | Topical | Systemic |
| Gentamicin Framycetin Fusidic acid Marbofloxacin Miconazole Polymyxin B |
Amoxicillin-clavulanic acid Cefalexin Enrofloxacin Itraconazole |
Fusidic acid Framycetin Marbofloxacin Miconazole Polymyxin B |
Cefalexin Clindamycin Enrofloxacin Fluconazole Itraconazole |
NDM: New-Delhi metallo-beta-lactamase producing.
a In addition, the dogs had received local and systemic corticosteroids.